Literature DB >> 16593069

Selecting the highest probability in binomial or multinomial trials.

B Levin1, H Robbins.   

Abstract

Some sequential procedures are considered for selecting the binomial population with largest success probability or for selecting the multinomial outcome with highest cell probability. Procedures with and without sequential elimination of inferior populations are evaluated with respect to the expected probability of the population selected.

Year:  1981        PMID： 16593069      PMCID： PMC320217          DOI： 10.1073/pnas.78.8.4663

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  1 in total

1.  A sequential test for two binomial populations.

Authors:  H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205
  1 in total
  6 in total

1.  Selecting the highest of three binomial probabilities.

Authors:  P Zybert; B Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  On an Inequality That Implies the Lower Bound Formula for the Probability of Correct Selection in the Levin-Robbins-Leu Family of Sequential Binomial Subset Selection Procedures.

Authors:  Bruce Levin; Cheng-Shiun Leu
Journal:  Seq Anal       Date:  2013       Impact factor: 0.927

3.  Continuous evaluation of evolving behavioral intervention technologies.

Authors:  David C Mohr; Ken Cheung; Stephen M Schueller; C Hendricks Brown; Naihua Duan
Journal:  Am J Prev Med       Date:  2013-10       Impact factor: 5.043

4.  Added Value from Secondary Use of Person Generated Health Data in Consumer Health Informatics.

Authors:  P-Y Hsueh; Y-K Cheung; S Dey; K K Kim; F J Martin-Sanchez; S K Petersen; T Wetter
Journal:  Yearb Med Inform       Date:  2017-09-11

5.  Selecting promising treatments in randomized Phase II cancer trials with an active control.

Authors:  Ying Kuen Cheung
Journal:  J Biopharm Stat       Date:  2009       Impact factor: 1.051

6.  Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design.

Authors:  Bruce Levin; John L P Thompson; Bibhas Chakraborty; Gilberto Levy; Robert MacArthur; E Clarke Haley
Journal:  Clin Trials       Date:  2011-07-07       Impact factor: 2.486
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.